Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia

Author： Darkow Theodore  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.6, 2007-01, pp. : 481-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Patterns and Adherence among Patients with Chronic Hepatitis C Virus in a US Managed Care Population

By Mitra Debanjali   Davis Keith L.   Beam Cynthia   Medjedovic Jasmina   Rustgi Vinod  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 479-486

Blackwell Publishing

Access to resources Recommend Favorite

Treatment Patterns, Outcomes and Costs Among Elderly Patients with Chronic Myeloid Leukaemia: A Population-Based Analysis

By Joseph Menzin  

Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. : 737-746

Adis International

Access to resources Recommend Favorite

The Association between Adherence to Levodopa/Carbidopa/Entacapone Therapy and Healthcare Utilization and Costs among Patients with Parkinson's Disease: A Retrospective Claims-Based Analysis

By Delea Thomas E.  

CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. : 53-66

Adis International

Access to resources Recommend Favorite

Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure

By Hochhaus Andreas  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 18, 2007-12 ,pp. : 3257-3264

Informa Healthcare

Access to resources Recommend Favorite

Dasatinib Treatment for Imatinib Resistant or Intolerant Patients with Chronic Myeloid Leukaemia

By Li J   Xu G   Yu S   He L   Guo L  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 337-347

Field House Publishing

Access to resources Recommend Favorite